Posts filtered by tags: GlaxoSmithKline[x]


 

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.
Tags: Health, GlaxoSmithKline


Factbox-Front Runners in Development of Antibody Drugs Against COVID-19

(Reuters) - AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest players to have developed COVID-19 treatments using a class...
Tags: GlaxoSmithKline, Reuters AstraZeneca Eli Lilly Regeneron


A drugmaker backed by the company that owns Marlboro cigarettes plans to launch the world's first plant-based COVID-19 vaccine

A nurse is inoculated with the Pfizer/BioNTEch coronavirus vaccine in Toronto, Canada, December 14, 2020. REUTERS/Carlos Osorio A Japanese drugmaker plans to submit data for a plant-based COVID-19 vaccine to Canadian regulators. The vaccine is made using a relative of the tobacco plant. Medicago, which is making the vaccine, is part-owned by tobacco giant Philip Morris International. The world's first plant-based COVID-19 vaccine could reach Canada's drug regulator by the end of th...
Tags: Health, Japan, UK, Science, News, Trends, Canada, Healthcare, GlaxoSmithKline, Pfizer, Vaccine, Quebec, Financial Times, Marlboro, Transparency Market Research, Toronto Canada


Photo Essay: As we celebrate the first malaria vaccine, remembering the epidemic's staggering toll

Arek Nuoi, 32 and a mother of four, arrives unconscious at the health center in Panthou village, carried in by her three brother-in-laws. The family lifted Arek onto a chair that they had tied on top of a bicycle, and pushed from their home village of Maper to the health care, a journey that took one and a half hours. Diana Zeyneb Alhindawi The first malaria vaccine has been approved. Malaria kills 400,000 people a year, mostly in sub-Saharan Africa. Photographer Diana Zeyneb Alhindawi do...
Tags: Health, UK, Science, News, Africa, Trends, Healthcare, South Sudan, Who, GlaxoSmithKline, Ssp, Malaria, World Health Organization WHO, Salva Kiir, Saharan Africa, Kiir


10 Things in Politics: Bernieworld plots its political future

Welcome back to 10 Things in Politics. Sign up here to receive this newsletter. Plus, download Insider's app for news on the go - click here for iOS and here for Android. Send tips to [email protected] your calendar: The coronavirus pandemic created a caregiving crisis, and working parents have paid a steep price. Join Insider on October 14 for a live event that explores how organizations can support caregivers.Here's what we're talking about:The Bernieworld diaspora: We'...
Tags: Florida, New York, Texas, Congress, Senate, White House, Russia, Court, US, Los Angeles, Trends, Cnn, Fbi, Democrats, United States, New York Times


‘Historic Moment’: W.H.O. Approves Rollout Of World’s First Malaria Vaccine

The malaria vaccine known as Mosquirix was developed by GlaxoSmithKline in 1987.
Tags: News, GlaxoSmithKline


The WHO recommends the world's first malaria vaccine, saying the shots could 'save tens of thousands of young lives each year'

A nurse prepares a syringe containing a malaria vaccine at the maternity ward of the Ewin Polyclinic, the first Ghanaian clinic to roll out the malaria vaccine Mosquirix or RTS,S, in Cape Coast, Ghana, on April 30, 2019. Cristina Aldehuela/AFP/Getty The World Health Organization recommended rolling out the world's first malaria vaccine Wednesday. Data from a pilot program in Africa shows four doses of the shot can reduce hospitalizations by 30%. Malaria kills 400,000 people a year, mos...
Tags: Africa, Trends, Who, World Health Organization, GlaxoSmithKline, Bill, Seattle, Malawi, Africa Health, Melinda Gates Foundation, Saharan Africa, Ghana Kenya, Tedros, Tedros Adhanom Ghebreyesus, Cristina Aldehuela, Cape Coast Ghana


Japan Approves GSK's Sotrovimab COVID-19 Antibody Treatment

TOKYO (Reuters) - Japan has approved GlaxoSmithKline and Vir Biotechnology's Sotrovimab as an antibody treatment for coronavirus, Health Minister...
Tags: Japan, Tokyo, GlaxoSmithKline, GSK, Reuters Japan, Sotrovimab


Activist Investor Bluebell Takes Stake in GSK - FT

(Reuters) - Activist investor Bluebell Capital Partners has taken a small stake in British pharmaceuticals group GlaxoSmithKline in efforts to...
Tags: GlaxoSmithKline, Reuters, GSK, Bluebell Capital Partners


Beyond COVID-19 vaccines, mRNA's pioneers have big plans for using the technology against a range of diseases

BI Graphics Employees in special suits test procedures for manufacturing the messenger RNA (mRNA) COVID-19 vaccine from Pfizer-BioNTech, in Marburg, Germany. Abdulhamid Hosbas/Anadolu Agency via Getty Images Drugmakers big and small are storming into messenger RNA research. The technology behind the first COVID-19 vaccines could help fight other diseases, including cancer. Early leaders in the mRNA space include Moderna, BioNTech, Pfizer, Sanofi, and GlaxoSmitKline. This artic...
Tags: Massachusetts, Trends, University of Pennsylvania, GlaxoSmithKline, Pfizer, Epstein Barr, Sanofi, GSK, Chikungunya, Rockville Maryland, Paul Hudson, Moderna, Andrew Dunn, Stéphane Bancel, BioNtech, COVID


GSK v. Teva: Skinny Label Approval is not a Patent Safe Harbor

In an important pharma decision, the Federal Circuit has doubled-down on its prior ruling that Teva’s sales of the drug carvedilol induced infringement of a GSK method-of-treatment patent, even though Teva’s product is approved and labeled only for non-infringing uses (as required by statute).  In the new decision, however, the court makes clear that the inducement liability is due to Teva’s additional marketing activity that encouraged others to infringe. GlaxoSmithKline v. Teva Pharm (Fed. Cir...
Tags: Law, Congress, US, Fda, GlaxoSmithKline, Patent, Newman, Moore, GSK, Teva, Federal Circuit, Prost, Teva Pharm Fed, Skinny Label Carveout


Coronavirus live news: Olympics faces last minute cancellation if cases rise; 4 million excess deaths in India

Tokyo 2020 could make late call on whether Games begin if cases surge; excess deaths in India are measure of overall impact of pandemicIndia’s excess deaths during Covid ‘could be 10 times official toll’China reports highest number of Covid cases since JanuaryMuslims across Indonesia mark grim Eid al-Adha as Covid crisis deepensRising Covid cases spark fears of resurgent pandemic in USSee all our coronavirus coverage 3.25pm BST Europe’s drug regulator has started a real-time review of the v...
Tags: Europe, Milan, Indonesia, China, India, World news, Britain, Italy, Tokyo, GlaxoSmithKline, Financial Times, Reuters, Sanofi, European Medicines Agency, Coronavirus, Giovanni Apolone


Drugmaker GSK Plans $550 Million Expansion of England R&D Facility

(Reuters) -Britain's GlaxoSmithKline on Friday laid out plans to set up a new life sciences campus within its R&D site in Stevenage, England,...
Tags: England, GlaxoSmithKline, Reuters Britain, GSK


Italy Approves GSK-Vir Antibody to Treat COVID-19

MILAN (Reuters) - Italy approved the temporary distribution of a coronavirus antibody treatment by Britain's GlaxoSmithKline and U.S. company Vir...
Tags: Milan, Britain, Italy, GlaxoSmithKline, Reuters Italy


Upstart insurers struggle - The future of GSK - Experts are masking up

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We compared the four health insurance upstarts that have gone public this year;Why a top biotech analyst thinks an activist investor is getting one big thing wrong about GSK; .If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Clover Health; Bright Health; Oscar Health; Olivia Reaney/Business Insid...
Tags: Cdc, Trends, Healthcare, Delta, Fda, GlaxoSmithKline, Pfizer, Goldman, Elliott, GSK, Elliott Management, Newsletters, PAREXEL, Eric Topol, Moderna, Bright Health


Investor Elliott Urges GSK to Consider Sale of Consumer Health

LONDON (Reuters) - Activist investor Elliott urged GlaxoSmithKline to consider the sale of its consumer healthcare business, which is being listed...
Tags: London, GlaxoSmithKline, Reuters, Elliott, GSK, Consumer Health


Investor Elliott Puts Pressure on GSK Leadership

By Keith WeirLONDON (Reuters) -Activist investor Elliott said GlaxoSmithKline should review its leadership and consider the outright sale of its...
Tags: GlaxoSmithKline, Reuters, Elliott, GSK Leadership, Keith WeirLONDON


Investor Elliott Wants GSK Leadership Settled Before Split

By Keith WeirLONDON (Reuters) -Activist investor Elliott said GlaxoSmithKline should review its leadership and consider a sale of its consumer...
Tags: GlaxoSmithKline, Reuters, Elliott, GSK, Keith WeirLONDON


A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs

Hi, Good morning, and welcome back to Insider Healthcare. I'm Andrew Dunn, and today in healthcare news:A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs;The US will likely miss Biden's July 4 vaccination goal;GlaxoSmithKline faces a critical investor day as activist investor pressure increases.If you're new to this newsletter, sign up here. And let me know what we should be paying attention to going forward: [email protected] On t...
Tags: Europe, White House, US, America, Trends, Getty Images, Alzheimer's Disease, Healthcare, Fda, GlaxoSmithKline, Pfizer, Biden, Fairfax Media, Chadwick Boseman, Elliott, GSK


The 20 fastest-growing, highest-paying biotechs

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We rounded up the 20 fastest growing drugmakers that pay the most;The recently approved Alzheimer's treatment could change the way we pay for drugs;5 questions facing GlaxoSmithKline ahead of a big investor meeting.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... FILE PHOTO: A technician works...
Tags: Texas, Obama, US, Trends, Compensation, Healthcare, Delta, Medicare, Fda, GlaxoSmithKline, Biotech, Humana, GSK, William Burke, Biogen, Newsletters


GSK Consumer Arm Confident That Growth, Cash Flow Will Help With Debt

By Ludwig Burger(Reuters) - Strong cash flow and growth will enable GlaxoSmithKline's consumer products business to cope with a higher debt load...
Tags: GlaxoSmithKline, GSK, Ludwig Burger Reuters Strong


Production of Another COVID-19 Vaccine to Begin in Weeks

Pharma firms Sanofi and GlaxoSmithKline say they will begin production of another potential vaccine against COVID-19 within weeks.
Tags: GlaxoSmithKline, Sanofi


What's at stake for the next wave of coronavirus vaccines

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We looked at how the next set of COVID-19 vaccine candidates are shaping up;A consolidation tsunami is headed for digital healthcare;We found 5 key takeaways from Bright Health's IPO filing.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Kate Bingham, Chair of the Government's Vaccine...
Tags: London, Ipo, US, Trends, Healthcare, Food And Drug Administration, GlaxoSmithKline, Vaccine, Digital Health, Cb Insights, Acquisitions, Jpmorgan, Andrew, Blake, Sanofi, Allison


These are the fastest-growing biotech companies

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We found the 29 fastest-growing biotechs;Sanofi and GSK get promising results for their COVID-19 shot;Amazon is launching a diagnostics brand, Insider has learned.If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... The biotech Moderna is working to develop personalized cancer treatments that are cust...
Tags: Amazon, US, Trends, Paris, Healthcare, Medicare, GlaxoSmithKline, Vaccine, Biotech, Clover Health, Sanofi, GSK, Newsletters, Diagnostics, Moderna, Reuters Sanofi


After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial

By Ernie Mundell and Robin Foster HealthDay ReportersMONDAY, May 17, 2021 (HealthDay News) -- Sanofi and GlaxoSmithKline announced Monday that...
Tags: GlaxoSmithKline, Robin Foster, Ernie Mundell, HealthDay News Sanofi


Sanofi-GSK Reports Success in Virus Vaccine, After Setback

Sanofi and GlaxoSmithKline’s potential COVID-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials.
Tags: GlaxoSmithKline, Sanofi, Sanofi GSK


Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

Sanofi CEO Paul Hudson Reuters Sanofi and GlaxoSmithKline said that their experimental COVID-19 vaccine succeeded in a mid-stage trial. The pharma giants plan to launch a pivotal-stage study with 35,000 volunteers in the coming weeks. The shot suffered from disappointing data and delays in 2020. The companies now hope for approval by year's end. See more stories on Insider's business page. One of the world's most closely watched coronavirus vaccine programs reported positive d...
Tags: Health, Science, Microsoft, US, Trends, Healthcare, GlaxoSmithKline, Johnson Johnson, Sanofi, GSK, Pharmaceutical, Andrew Dunn, Emma Walmsley, Coronavirus, Coronavirus Vaccine, Dispensed


Sanofi/GSK Report Positive Interim Results for Their COVID-19 Shot

By Matthias BlamontPARIS (Reuters) -An experimental COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in...
Tags: GlaxoSmithKline, Reuters, Sanofi, Matthias, Sanofi GSK


CureVac-GSK Coronavirus Variant Vaccine Generates Good Immune Response in Rats

By Alistair SmoutLONDON (Reuters) - A second-generation COVID-19 vaccine developed by CureVac and GlaxoSmithKline, designed to protect against...
Tags: GlaxoSmithKline, CureVac, Alistair SmoutLONDON Reuters


The 4 best at-home DNA test kits for genetics, health, and ancestry, according to geneticists and genealogists

Table of Contents: Masthead Sticky At-home DNA kits give insight into your ancestry and health information and can help connect you with family. We spoke with six genetics experts on what to look for in an at-home DNA kit. Our top pick, AncestryDNA, has the largest database and gives a detailed ethnicity report for $100. It's quite amazing that with a simple saliva sample or cheek swab, we can learn so much about our ancestry, family connections, and inherited health markers - all thanks...
Tags: Reviews, Facebook, Europe, China, Dna, Africa, Americas, Trends, Features, Guides, Ireland, Buying Guide, Fda, GlaxoSmithKline, Smith, Ancestry